The CBI combines the research and development, and manufacturing expertise and capabilities of the industry partners and The University of Queensland (UQ). Industry-driven research projects ensures industry-ready graduates drive growth in the sector. The CBI is located within the Australian institute for Bioengineering and Nanotechnology (AIBN) at UQ and collaborates with the National Biologics Facility, also located within the AIBN.
The Centre will conduct research projects within three thematic areas:
- Discovery of new biopharmaceuticals and diagnostic agents
- Development of mammalian cells as factories for recombinant protein production
- Advanced manufacturing of biopharmaceuticals
The training and research outcomes of the CBI will lead to new biopharmaceuticals and antibody-based reagents, enhanced production methods, improved manufacturing capabilities and a cohort of specialist scientists, which will benefit the economy and positively impact health-care.
The CBI partners with leading Australian stakeholders in the biologics industry including CSL Limited, GE Healthcare, the Australian Red Cross Blood Service and Patheon Biologics Australia Pty Ltd.